Around The Web

"A classroom program that helps teachers adapt their interactions with students based on individuals' temperaments may lead to more student engagement in kindergarten, more...

Drug makers have faced large fines for unethical and harmful practices but have simply treated these as a cost of doing business. Ed Silverman reports...

Ed Silverman reports that only 80 prescriptions for Addyi, or Flibanserin, were filled in the drugs’ first two weeks on the market. Article →

In The Atlantic, Julie Beck interviews emotional intelligence expert David Caruso about the importance of accurately recognizing and communicating your emotions. “American culture demands that the answer to the question ‘How are you?’ is not just ‘Good,’ but sometimes ‘Great.’ Or—this drives folks around the world crazy, who might be based in another country but they work for an American company—we need to be ‘Awesome.’ There's this relentless drive to mask the expression of our true underlying feelings. It's almost inappropriate.”

The BMJ reports that renewed concerns about the “revolving door” between government and industry have been sparked by the health minister of England’s decision to join to drug company Roche.

“The point, overall, is that given the dizzying array of possible factors at work here, it’s much too pat a story to say that kids are getting more 'fragile' as a result of some cultural bugaboo,” Jesse Singal writes in response to the flurry of recent think pieces decrying the weakened resolve of today's college students.

Will Davies, author of The Happiness Industry, does a Q&A on the ways companies are misusing psychological research on happiness. “I think that one thing that often gets lost in lots of the discussions of happiness (especially in the business world) is the possibility that happy work may mean less work.”

A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines “shy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though...

The latest research shows that the effect of the “moral molecule” oxytocin has a much more complicated effect on human behavior than we think, according to Ed Yong in a recent article for The Atlantic. “Several scientists have shown that this tower of evidence for oxytocin’s positive influence is built on weak foundations,” he writes.

“In America, medication is becoming almost as much a staple of childhood as Disney and McDonald’s,” writes Sarah Boseley in the Guardian. In this piece photographer Baptiste Lignel follows six boys and girls to examine the long-term effects of these drugs.

Children diagnosed with ADHD who are prescribed stimulant drugs have more sleep problems than those with ADHD that do not take these drugs.

Peter Holley reports for the Washington Post that a powerfuland highly addictive amphetamine drug known as fenethylline or Captagon is being used to fuel ISIS fighters in Syria and Iraq. “Captagon has been around in the West since the 1960s, when it was given to people suffering from hyperactivity, narcolepsy, and depression.”

The Atlantic compares the use of meth as a “top-line antidepressant” in the 1930s to the 1950s to debates over the use of medicinal marijuana today. “It’s an example of how pharmaceuticals, at their core, are drugs. They’re chemicals that were mixed together and believed to be beneficial to humanity, until they weren't.”

“Doctors say one of the best anti-depressants isn't even a drug, it's exercise,” CNN reports. “Experts say many cases of depression can be treated effectively with, for example, a pair of running shoes.”

David Shern, from Johns Hopkins University, writes that the latest mental health “Murphy bill” in Congress is “an expansion of the approaches that got us into our current difficulties.” “Early intervention and prevention, assessable and patient-focused services with a rehabilitation orientation and increased funding for the community supports needed for successful recovery are the tickets to system improvement.”

In this short audio clip, psychologist Sheldon Solomon discusses what research on our unconscious fears about death can tell us about terrorism, intolerance, and radicalism. “In the wake of the Paris attacks, we examine the worm that some people think is eating away at our core — our fear of death.”

Day 3 of WNYC Only Human’s radio show, called Listen Up, focuses on the importance of listening with empathy. They interview Ken Feinberg, a mediator who met with victims after the September 11th attacks, the Sandy Hook shootings, and the Boston marathon bombing.

While plans to involuntary commit drug users have “received virtual across-the-board support,” Susan Sered from TruthOut reports that “there is little to no evidence showing that coerced drug treatment is effective,” and that “having abstained from opiates for several days may set them up to overdose when they return to their former level of drug use, with a reduced tolerance for the drugs.”

On The Daily Show, Michael Che interviews MIA contributor Peter Gøtzsche and discovers that pharmaceutical companies and drug cartels have more in common than one might think.

Joan Cook, professor of Psychology at Yale, writes than in her work with military veterans she realized that her psychotherapy techniques mattered much less than her training had indicated. Instead, what mattered was “the bond forged over years of therapy,” known as “the therapeutic alliance.”

A new study suggests that service members who take stimulant medications to stay alert are five times more likely to suffer from post-traumatic stress disorder, the LA Times reports. “Those who had been prescribed multiple stimulants and the biggest supplies of the drugs were the most likely to have PTSD.”

Will Storr, for Mosaic Science, wades into the world of neuroplasticity and explores to what extent our brains are capable of changing through adulthood. He asks if the tendency to overemphasize the findings of epigenetics and neuroplasticity isn’t tied to our cultural belief that individuals are totally free to create themselves and pursue the American dream.

With the American Medical Association (AMA) declaring its opposition to direct-to-consumer (DTC) drug advertising, Martha Rosenberg asks, did DTC increase the number of people who have "diseases"?

The Scientific American reprints their interview with psychologist and terrorism expert John Horgan following the attacks in Paris on November 13th. “An issue I find problematic right now is the idea that to prevent terrorism, we have to first prevent radicalization… There are far more people who hold "radical" views than will ever become involved in terrorism, and there are plenty of terrorists (who are already small in number – a point we tend to forget) who don’t initially hold radical views but drift into terrorism regardless.”

"We found that the anatomy of the chimpanzee brain is more strongly controlled by genes than that of human brains, suggesting that the human brain is extensively shaped by its environment no matter its genetics," said Aida Gómez-Robles, postdoctoral scientist at the GW Center for the Advanced Study of Human Paleobiology and lead author on the paper. "So while genetics determined human and chimpanzee brain size, it isn't as much of a factor for human cerebral organization as it is for chimpanzees."